Gentamicin treatment in McArdle disease: failure to correct myophosphorylase deficiency

Neurology. 2006 Jan 24;66(2):285-6. doi: 10.1212/01.wnl.0000194212.31318.fc.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Cells, Cultured
  • Energy Metabolism
  • Female
  • Gentamicins / administration & dosage
  • Gentamicins / pharmacology
  • Gentamicins / therapeutic use*
  • Glycogen Phosphorylase, Muscle Form / deficiency*
  • Glycogen Phosphorylase, Muscle Form / genetics
  • Glycogen Phosphorylase, Muscle Form / metabolism
  • Glycogen Storage Disease Type V / drug therapy*
  • Glycogen Storage Disease Type V / enzymology*
  • Glycogen Storage Disease Type V / genetics
  • Humans
  • Magnetic Resonance Spectroscopy
  • Male
  • Middle Aged
  • Muscle, Skeletal / enzymology
  • Mutation
  • Myoblasts / drug effects
  • Myoblasts / enzymology
  • Osmolar Concentration
  • Phosphorylases / metabolism

Substances

  • Gentamicins
  • Glycogen Phosphorylase, Muscle Form
  • Phosphorylases